CDK4/6 inhibitors in invasive disease-free survival of breast cancer patients
Free CME-accredited Webinar
December 11, 2023 | 4:30pm EDT I 6:30pm BRT
About The Event
Join us for this CME-accredited webinar! The talks will focus on diagnosis and treatment of high-risk early breast cancer patients with a focus on the latest data from the clinical trials and how work up and treatment pathways may vary from country to country. This Ask-the-Expert webinar is designed for health care professionals (medical oncologists, surgical oncologists, radiation oncologists, breast surgeons, pathologists, and other members of the MDT,) who are interested in learning more on the latest research, treatment, and clinical management of patients with breast cancer. There will be the opportunity to ask questions to our panel during the live Q&A or you can send your questions prior to the event. So, register today to submit your questions!
This webinar is supported by Eli Lilly. Eli Lilly has had no influence over the content or selection of the Editorial Panel.
John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Wiley designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™ per e-learning. Physicians should claim only the credit commensurate with the extent of their participation in the activity.